Nina Gentile, MD, Professor of Emergency Medicine at the Lewis Katz School of Medicine at Temple University, presented the details and results of the I-SPOT trial at the International Stroke Conference in February. The American Heart Association included a write-up in its Professional Heart Daily newsletter, and Dr. Gentile participated in a video interview on the subject as well. The Insights on Selected Procoagulation Markers and Outcomes in Stroke (I-SPOT) trial was an ancillary study related to the Stroke Hyperglycemia Insulin Network Effort (SHINE) clinical trial. The goal was to study the effects of glucose levels and hyperglycemia control on blood coagulation markers and their relationships to functional neurological outcomes in patients with acute ischemic stroke. Dr. Gentile was the principal investigator of I-SPOT.
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH
Related News
Major Advances in Treating Lung Blood Clots Could Eliminate Need for ICU Stay, According to New Research at the Lewis Katz School of Medicine at Temple University
Posted November 22, 2024A novel “on-the-table” therapeutic strategy with a total procedure time of less than one hour can safely reduce the size of blood clots lodged in the pulmonary arteries and eliminate the need for post-procedural drug infusion in an intensive care unit, according to Katz School of Medicine research.
Read MoreHealio Highlights Dr. Kristin Criner’s Session at the GOLD International COPD Conference
Posted November 21, 2024Healio highlighted the key takeaways from Dr. Criner’s session on how to identify and treat patients with COPD plus diabetes or osteoporosis.
Read More